RYVU THERAPEUTICS SA PLN0.40RYVU THERAPEUTICS SA PLN0.40RYVU THERAPEUTICS SA PLN0.40

RYVU THERAPEUTICS SA PLN0.40

No trades
See on Supercharts

0RKT fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Ryvu Therapeutics SA engages in the provision of products and solutions for the pharmaceutical and biotechnology industry. Its projects and services include contract chemistry services, biology services, integrated drug discovery, and comparative studies of biosimilar medicinal products. The company was founded by Boguslaw Sieczkowski and Pawel Przewiezlikowski in 2007 and is headquartered in Krakow, Poland.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

0RKT does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company